Literature DB >> 33245813

From basic research to clinical application of γδ T cells.

Julie Déchanet-Merville1, Immo Prinz2.   

Abstract

Year:  2020        PMID： 33245813     DOI： 10.1111/imr.12931

Source DB:  PubMed          Journal:  Immunol Rev        ISSN： 0105-2896            Impact factor:   12.988


× No keyword cloud information.
  1 in total

1.  CD277 agonist enhances the immunogenicity of relapsed/refractory acute myeloid leukemia towards Vδ2+ T cell cytotoxicity.

Authors:  Tianhui Dong; Ning Wu; Haitao Gao; Shuang Liang; Xinyu Dong; Ting Zhao; Qian Jiang; Jiangying Liu
Journal:  Ann Hematol       Date:  2022-08-03       Impact factor: 4.030
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.